From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves Oxervate, the first drug to treat neurotrophic keratitis

from Healio

The FDA has approved Oxervate for treatment of neurotrophic keratitis, a progressive disease affecting the cornea in fewer than five in 10,000 people, according to an Agency press release. Oxervate (cenegermin), developed by Dompé farmaceutici SpA, is the first FDA approved drug for the rare disease, which can cause loss of corneal sensation and impair corneal health. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063